Pentagon hands Raytheon a $20.7B missile haul as Ukraine war grinds on — long RTX
Wars don't just make headlines — they create multi-year backlogs of weapons orders, and the Pentagon replacing stockpiles means contracts flow to established missile makers like Raytheon regardless of day-to-day market swings. The $20.7 billion AMRAAM award is one of the largest recent contract wins and locks in revenue visibility for years. Continued Russian strikes on Ukrainian military infrastructure show the demand driver isn't going away, and defense spending tends to rise across allies, not just the US. That makes RTX a relatively defensive way to own the conflict-driven news flow.
Idea
Wars don't just make headlines — they create multi-year backlogs of weapons orders, and the Pentagon replacing stockpiles means contracts flow to established missile makers like Raytheon regardless of day-to-day market swings. The $20.7 billion AMRAAM award is one of the largest recent contract wins and locks in revenue visibility for years. Continued Russian strikes on Ukrainian military infrastructure show the demand driver isn't going away, and defense spending tends to rise across allies, not just the US. That makes RTX a relatively defensive way to own the conflict-driven news flow.
Advanced Analysis — institutional-depth research report
Verdict: RTX's AMRAAM backlog is real, but the entry rules say wait
The strongest argument for this idea is the cash: Q2 2026 free cash flow jumped nearly 120% quarter over quarter to $2.9B, and RTX ranks in the 99th percentile of 661 Industrials peers on free cash flow, with the September 28, 2026 Reuters-reported $20.7B AMRAAM award adding multi-year revenue visibility. The strongest argument against is the texture behind the growth — net margin slipped from about 9.3% to 8.7% and operating margin from about 11.6% to 11.4% even as revenue rose 11.9%, while the most recent ownership filing (for the period ended June 30, 2026, not current) shows roughly $2.8M of net open-market insider selling across 23 holders. On timing, this is a watch-list setup, not an active signal: only the trend-strength condition is live (ADX near 40 vs. the 20 threshold), RSI (14) sits near 22 versus its 45 trigger, and price at $187.66 is 4.7% below the $196.47 EMA (20). No robust parameter setup was established — the sensitivity evaluation exceeded its time budget — and the research author requested a bounded search because the compiled thresholds produced zero entries across 1,235 daily bars. So the thesis has fundamental legs, but nothing to execute today.
Trade now: RTX entry is not armed — one condition is met, two are not
Nothing to execute today. RTX closed at $187.66, below the $196.47 EMA (20), and the strategy's long entry needs three things to line up: price crossing back above that EMA, RSI (14) above 45, and ADX (14) above 20. Right now only the trend-strength condition is live — ADX reads about 40 versus the 20 threshold. RSI sits near 22, more than 23 points below its trigger, and price has not crossed above the EMA, so the setup is on the watch list, not in the book. If the entry does trigger, the plan is already priced. The fixed-risk sizing targets a stop 2.6% below entry (roughly $182.86, near the second support level) and a take-profit 5.1% above entry (roughly $197.24, beyond the nearer resistance at $188), an effective reward-to-risk of about 2-to-1, with the $188 resistance as an interim cap. Position size is capped at 25% of the book per the risk rules. What "wait" means concretely: hold off until RSI (14) recovers through 45 and a daily close crosses above roughly $196.47. Note that the research author has requested a bounded parameter search because the compiled thresholds produced zero entries across 1,235 daily bars over 60-, 24-, and 12-month windows; the sensitivity evaluation ran out of its time budget, so no adjusted setup has been validated — today's levels are the live rules, and any revised thresholds would be published separately before touching a holdout.
The backlog thesis is already visible in the cash flow statement
The core of this thesis — that replenishment demand converts into years of contracted revenue — is showing up in the reported numbers. Q2 2026 revenue came in at $24.7B, up 11.9% quarter over quarter from $22.1B, and net income rose to $2.14B from $2.06B. The Reuters report on September 28, 2026 that the Pentagon awarded Raytheon a $20.7B AMRAAM contract is exactly the kind of multi-year backlog event the idea argues for, and the continuing Russian strikes on Ukrainian military infrastructure (per the September 27 Reuters report) suggest the underlying demand driver remains live rather than a one-quarter spike. Cash generation is where the bull case is strongest. Q2 free cash flow more than doubled sequentially to $2.88B, up 119.9% from $1.31B in Q1, on operating cash flow of $3.55B, up 91.2%.…
Scores
- Conviction score breakdown: 53
- Thesis support: 75
- Trade readiness: 40
- Risk quality: 55
- Trigger proximity: 25
- Fundamentals trend: 70
Watch items
- RTX — RSI (14)
- RTX — Daily close vs EMA (20)
- RTX — ADX (14)
- RTX — Price vs second support level
- RTX — Free cash flow
- RTX — Insider net open-market activity
- RTX — Quarterly dividend ex-date